Products for Research Use Only
RegisterLogin

Y2641

CAT: 0804-HY-174156Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-174156Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Y2641, a etrahydro-β-carboline derivative, is an orally active dual RANKL/TNF-α inhibitor with Kd values of 3.984 μM and 18.59 μM for RANKL and TNF-α, respectively. Y2641 inhibits RANKL-induced osteoclastogenic and has anti-inflammatory and cartilage destruction. Y2641 can be used for study of osteoarthritis[1].
UNSPSC
12352005
Target
RANKL/RANK ; TNF Receptor
Related Pathways
Apoptosis; NF-κB
Field of Research
Inflammation/Immunology
Smiles
O=C([C@@H]1CC(C2=CC=CC=C2N3)=C3C4(CN(C4)C5=CC=CC=C5)N1)NC6=C(C=CC=C6C)C
Molecular Formula
C28H28N4O
Molecular Weight
436.55
References & Citations
[1]Shao Z, et al. Identification of a RANKL/TNF-α Dual-Inhibitor as a Potential Disease-Modifying Agent for the Treatment of Knee Osteoarthritis. J Med Chem. 2025 May 22;68 (10) :10216-10237.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
GTR19263616-01Y2641

Popular Products